IsoRay, Inc Stock News

IsoRay (ISR) delivered earnings and revenue surprises of -100% and 56.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Isoray, Inc. (NYSE:ISR ) Q1 2023 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Thijs Spoor - CEO, Viewpoint Molecular Targeting Jonathan H

Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT

RICHLAND, Wash.

Isoray, Inc. (NYSE:ISR ) Q4 2022 Earnings Conference Call September 28, 2022 4:30 PM ET Company Participants Mark Levin - Investor Relations Lori Woods - Chief Executive Officer Thijs Spoor - Chief Ex

IsoRay (ISR) delivered earnings and revenue surprises of 0% and 13.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT

IsoRay (ISR) delivered earnings and revenue surprises of 0% and 7.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Oncternal Therapeutics (ONCT) delivered earnings and revenue surprises of -5.26% and 6.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT

RICHLAND, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy, today announced that Chief Executive Officer Lori Woods will participate in a virtual fireside chat at the Oppenheimer 32 nd Annual Healthcare Conference on Thursday, March 17 at 1:20 p.m. ET. CEO Woods and Chief Financial Officer Jonathan Hunt will also host virtual one-on-one and group meetings with institutional investors during the conference.

PolarityTE, Inc. (NASDAQ:PTE) with the stream of -4.05% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of -4.52% in the last hour of Monday’s trading session. PolarityTE, Inc. … The post Exceptional Stock in Review: PolarityTE, Inc. (NASDAQ:PTE), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Investigators from the University of Pittsburgh School of Medicine have published a clinical study demonstrating favorable outcomes for localized intermediate-risk prostate cancer patients treated with IsoRay Inc''s (NYSE: ISR ) Cesium-131 brachytherapy known as Cesium Blu. Brachytherapy is a localized internal radiation therapy in which seeds, ribbons, or capsules containing … Full story available on Benzinga.com

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) with the stream of 5.73% also noticed, India Isoray, Inc. (AMEX:ISR) encountered a rapid change of 3.76% in the last hour of trading session. Qualigen Therapeutics, … The post Sizzling Stock Update: Qualigen Therapeutics, Inc. (NASDAQ:QLGN), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .

Isoray, Inc. (NYSE:ISR) Q2 2022 Earnings Conference Call Feb 08, 2022, 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants